G1 Therapeutics (STU:G1H) ROE % Adjusted to Book Value : -17.69% (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is G1 Therapeutics ROE % Adjusted to Book Value?

G1 Therapeutics's ROE % for the quarter that ended in Jun. 2024 was -84.04%. G1 Therapeutics's PB Ratio for the quarter that ended in Jun. 2024 was 4.75. G1 Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -17.69%.

G1 Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for G1 Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G1 Therapeutics ROE % Adjusted to Book Value Chart

G1 Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-10.23

-11.31

-31.87

-36.29

-21.07

G1 Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															30.73	-91.86	-25.56	-15.56	-17.69

Competitive Comparison of G1 Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, G1 Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G1 Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G1 Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where G1 Therapeutics's ROE % Adjusted to Book Value falls into.

Save

G1 Therapeutics ROE % Adjusted to Book Value Calculation

G1 Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-90.37%	/	4.29
	=	-21.07%

G1 Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-84.04%	/	4.75
	=	-17.69%

G1 Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of G1 Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

G1 Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G1 Therapeutics Inc (STU:G1H) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 Park Offices Drive, Suite 200, Research Triangle Park, NC, USA, 27709

Website

https://www.g1therapeutics.com

G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat the types of cancer, such as cell lung cancer and breast cancer, and designs them to combine and enhance the anti-tumor activity of current therapies. Its product COSELA indicates to help protect bone marrow from the damage of chemotherapy.

G1 Therapeutics Headlines

No Headlines